Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

When you are pregnant, you have so many questions about your baby. Prenatal testing can answer some of those questions. Noninvasive prenatal testing (NIPT) can tell you whether your baby is at risk ...

LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...

Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...

prenatal genetic testing Published practice bulletins offer guidance to clinicians on patient education during pregnancy. To provide women with accurate information regarding genetic screening and ...

In their latest recommendation statement, the US Preventive Services Task Force (USPSTF) recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders. A version of ...

Our team of maternal-fetal medicine specialists and prenatal genetic counselors have extensive training and experience in prenatal genetic testing. Providers throughout the Mountain West regularly ...

Prenatal genetic testing determines if an offspring is at risk of genetic or hereditary conditions. This can inform the parents of decisions such as keeping the child or not or adjusting to help them ...

For anyone who has paid any attention to prenatal screening, abortion and Down syndrome in recent years, it will come as no surprise that increased availability of prenatal screening leads to a ...

Please provide your email address to receive an email when new articles are posted on . The FDA is warning the public about the risks for false results and inappropriate interpretation of results from ...

A disturbing report from The New York Times on the unreliability of prenatal blood testing for genetic abnormalities should do more than make us wish that the testing companies were better regulated.